Pharmaceutical Supply – Bupivacaine Hydrochloride Injection

The contract requires the manufacture and supply of 5,000 units of Bupivacaine Hydrochloride Injection, identified by NSN 6505011277946 and NDC 00143-9334-10, to meet stringent FDA regulations, current Good Manufacturing Practices, and Department of Defense traceability requirements. The product must be produced under fully compliant conditions and documented to ensure full accountability and quality assurance throughout the supply chain. Delivery is specified for the Defense Logistics Agency in Suffolk, Virginia, with all units expected to conform to military medical standards for storage, labeling, and distribution. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, and falls under NAICS code 325412 for pharmaceutical preparation manufacturing. The contract was posted on August 9, 2026, and is not subject to any set-aside provisions. The award reference is SPE2D926F8039 with underlying contract SPE2DX25D8022, with fulfillment tied to specific DLA logistics and inventory systems. Compliance with DoD traceability protocols is critical, ensuring each unit can be tracked from production through final issue to military medical facilities.